Generic drug of the therapeutic class: Anesthesia, resuscitation, analgesics
Active ingredients: Articaine, Adrenaline
Injectable solution for dental use
Box of 100 cartridges of 1.8 ml
Local or loco-regional anesthesia in odonto-stomatological practice.
Dosage ALPHACAINE N 1/200 000 Solution for injection for dental use Box of 100 cartridges of 1.8 ml
Reserved for adults and children from 4 years, due to the type of anesthesia not adapted before this age.
The quantity to be injected will be adapted according to the importance of the intervention.
As a rule, one to three cartridges per session.
Do not exceed the dose of 7 mg articaine hydrochloride per kilogram of body weight.
Child (over 4 years old)
The quantity to be injected depends on the age, the weight of the child and the type of intervention to be performed.
The maximum dose is 5 mg of articaine hydrochloride (0.125 ml of anesthetic solution) per kilogram of body weight.
The average dose in mg of articaine hydrochloride, which can be administered in children, can be calculated as follows:
· Child's weight (in kilograms) × 1.33.
Half of the dose reserved for adults.
LOCAL OR REGIONAL INJECTION INTRA-ORAL UNDER MUCOUS.
Verify that there is no vascular intrusion by repeated aspiration tests, especially during regional (truncular) anesthesia.
The injection speed must not exceed 1ml of solution per minute.
This drug is contraindicated in case of hypersensitivity to local anesthetics or any of the components, and in the following situations:
· Severe and uncomplicated atrioventricular conduction disorders;
Epilepsy not controlled by treatment;
· Acute intermittent porphyria.
This drug is generally not recommended in combination with certain drugs such as guanethidine and related products (see section 4.5 ).
Alphacaine N side effects
As with all anesthetics used in odonto-stomatology, lipothymia can occur.
Due to the presence of sodium metabisulfite, risk of allergic reactions, including anaphylactic reactions and bronchospasm
In case of overdose or in certain predisposed patients, the following clinical signs may be observed:
· On the central nervous system :
nervousness, agitation, yawning, trembling, apprehension, nystagmus, logorrhea, headache, nausea, tinnitus.
These signs of call require to ask the patient to hyperventilate, as well as a careful monitoring to prevent a possible aggravation with convulsions then depression of the CNS.
· On the respiratory system :
tachypnea then bradypnea can lead to apnea.
· On the cardiovascular system :
tachycardia, bradycardia, cardio-vascular depression with hypotension that may lead to collapse, rhythm disturbances (ventricular extrasystoles, ventricular fibrillation), conduction disturbance (atrioventricular block).
These cardiac manifestations can lead to cardiac arrest.